Acura Pharmaceuticals - 15 Year Stock Split History | ACUR
Stock split history for Acura Pharmaceuticals since 2011. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.000B | $0.000B |
| Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $37.024B | 11.42 |
| BridgeBio Pharma (BBIO) | United States | $13.499B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.610B | 22.80 |
| Aspen Pharmacare (APNHY) | South Africa | $4.116B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.582B | 18.23 |
| Taysha Gene Therapies (TSHA) | United States | $1.876B | 0.00 |
| Bausch Health Cos (BHC) | Canada | $1.747B | 1.19 |
| Personalis (PSNL) | United States | $1.065B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.808B | 7.48 |
| Assembly Biosciences (ASMB) | United States | $0.400B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.207B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.045B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |